Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-02-25 @ 8:11 PM
Study NCT ID:
NCT04672005
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2020-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer
Sponsor:
Lyudmyla Berim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-09
First Submit QC Date:
None
Study First Post Date:
2020-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-13
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL